Helvepharm AG - Fesoterodin Zentiva 8 mg, Retardtabletten | | 68694 | | 02 | | Fesoterodin Zentiva 8 mg | | Retardtabletten | | G04BD11 | | Fesoterodin | | 31.03.2022 | | |
| Composition | fesoterodini fumaras 8 mg corresp. fesoterodinum 6.2 mg, glyceroli dibehenas, hypromellosum, talcum, lactosum monohydricum 124.125 mg, cellulosum microcristallinum, Überzug: poly(alcohol vinylicus), talcum, E 171, E 132, E 172 (rubrum), glyceroli monocaprylocapras, natrii laurilsulfas, pro compresso obducto corresp. natrium 0.046 mg. | Packungsbestandteile | | Comprimés retards | | | Principe actif | Concentr. |
---|
Fesoterodini Fumaras | 8 mg correspond Fesoterodinum 6.2 mg |
| BAG: Principe actif | Concentr. |
---|
Fesoterodini Fumaras | 8 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Rubrum) | | | Cellulosum Microcristallinum | | | E 132 | | color. | E 171 | | color. | E 172 | | color. | Glyceroli Dibehenas | | | Glyceroli Monocaprylocapras | | | Hypromellosum | | | Lactose Monohydrate | 124.125 mg | | Natrii Laurilsulfas | | | Poly(Alcohol Vinylicus) | | Überzug | Pro Compresso Obducto | | | Talcum | | |
| |
| |
|